Hereditary Angioedema clinical trials at UC Health
1 in progress, 0 open to eligible people
Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
Sorry, in progress, not accepting new patients
This study is an open-label, long term safety and efficacy study to evaluate DX-2930 in preventing acute angioedema attacks in participants with Type I and Type II HAE.